Grant Received from the Bill & Melinda Gates Foundation to Fund Development of Affordable TherapeuticsJUPITER, Fla., Nov. 21, ...

Dyadic international was awarded a $3 million grant from the Bill & Melinda Gates Foundation to fund the development of ...

Dyadic International (DYAI) announced that it has been awarded a $3M grant from the Gates Foundation for the cell line development of monoclonal antibodies targeting respiratory syncytial virus and ...

Dyadic International, Inc. (NASDAQ:DYAI) Q3 2024 Earnings Call Transcript November 16, 2024 Operator: Operator: Good evening, ...

Revenue: Revenue for the three months ended September 30, 2024, increased to approximately $1,958,000 compared to $397,000 ...

总之，Dyadic International 2024年第三季度业绩电话会议揭示了公司财务状况强劲，在产品开发和商业化方面取得重大进展。公司的战略合作伙伴关系以及对生物技术板块高增长领域的关注，使其为持续成功奠定了良好基础。 Dyadic ...

Good evening, and welcome to Dyadic International Q3 2024 Conference Call. Currently, all participants are in a listen-only mode. Following management’s prepared remarks, there will be a brief ...

Revenue exceeded analyst estimates by 78%. Earnings per share (EPS) also surpassed analyst estimates by 86%. Looking ahead, ...

Analysts at HC Wainwright issued their FY2024 earnings estimates for Dyadic International in a research note issued to investors on Wednesday, November 13th. HC Wainwright analyst V. Bernardino ...